March 2, 2025 - 02:17

A recent study published in Clinical Diabetes highlights the potential of new diabetes technology to improve health outcomes for individuals with type 1 diabetes. Researchers from the University of Colorado Anschutz Medical Campus and Massachusetts General Hospital have found that when trained by a primary care provider or through telehealth, patients can effectively utilize the iLet Bionic Pancreas system. This technology, which was previously only examined in specialized endocrinology settings, shows promise in broadening access to care for those who may have difficulty visiting a specialist.
The findings suggest that integrating advanced diabetes management tools into primary care can empower patients to manage their condition more effectively. This approach not only enhances the quality of care but also addresses barriers faced by many individuals in accessing specialized diabetes treatment. By leveraging telehealth and training from primary care providers, the iLet Bionic Pancreas system could become a vital resource in improving the lives of those living with type 1 diabetes.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...